A review of preclinical evidence finds THC and CBD have anticancer effects in cervical cancer through apoptosis, proliferation inhibition, and immune modulation, with nanotechnology-based delivery systems showing enhanced efficacy.
Cancer researchers, oncologists, and anyone following cannabinoid anticancer research.
Multiple anticancer mechanisms identified in preclinical cervical cancer studies
What the researchers found
THC and CBD demonstrate anticancer effects in cervical cancer cells by inducing apoptosis, inhibiting proliferation, suppressing metastasis, promoting oxidative stress, and modulating immune responses. Combining cannabinoids with chemotherapy, radiotherapy, or immunotherapy enhanced efficacy and reduced drug resistance. Nanoparticle delivery systems improved targeting, solubility, and reduced systemic toxicity.
Why it matters
Cervical cancer remains a major health challenge, particularly in sub-Saharan Africa. Cannabinoids represent a new class of potential therapeutic agents, and nanotechnology may solve key delivery challenges that have limited their clinical application.
The numbers in context
Review covers multiple mechanisms: apoptosis induction, proliferation inhibition, metastasis suppression, oxidative stress promotion, immune modulation. Combination approaches with chemo, radio, and immunotherapy reviewed.
How the study worked
Critical synthesis of preclinical studies examining cannabinoid anticancer properties in cervical cancer, including combination therapy approaches and nanotechnology-based delivery platforms.
What this study cannot tell us
All evidence is preclinical. No human clinical trials for cannabinoids in cervical cancer exist. Optimal formulations, doses, and delivery routes remain to be determined. Regulatory challenges for cannabinoid-based medicines persist.
How to read the evidence
Review of preclinical evidence only. No human clinical data for this specific application.
When this study was published
Published in 2025.
The bigger picture
The convergence of cannabinoid research with nanotechnology and combination therapy represents a new frontier in cancer treatment. If these preclinical findings translate clinically, cannabinoid-based nanoformulations could complement existing cervical cancer treatments.
Questions still open
- When will the first clinical trials of cannabinoid nanoformulations for cervical cancer begin? Could these approaches also work for HPV-related cancers beyond the cervix?
Common questions
Can cannabinoids treat cervical cancer?
Why nanotechnology?
Read the original research
Advancing cervical cancer treatment: integrating cannabinoids, combination therapies and nanotechnology.
Journal of cancer research and clinical oncology, 151(11), 294
Citation
Mathibela, S P; Ncube, K N; Lebelo, M T; Steenkamp, V. (2025). Advancing cervical cancer treatment: integrating cannabinoids, combination therapies and nanotechnology.. Journal of cancer research and clinical oncology, 151(11), 294. https://doi.org/10.1007/s00432-025-06323-6
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk